These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16533709)

  • 1. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease.
    Whitworth AJ; Wes PD; Pallanck LJ
    Drug Discov Today; 2006 Feb; 11(3-4):119-26. PubMed ID: 16533709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila models of Parkinson's disease.
    Whitworth AJ
    Adv Genet; 2011; 73():1-50. PubMed ID: 21310293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of
    Vos M; Klein C
    Cells; 2021 Mar; 10(3):. PubMed ID: 33800736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
    Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
    J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease.
    Trinh K; Moore K; Wes PD; Muchowski PJ; Dey J; Andrews L; Pallanck LJ
    J Neurosci; 2008 Jan; 28(2):465-72. PubMed ID: 18184789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling Parkinson's disease in Drosophila.
    Botella JA; Bayersdorfer F; Gmeiner F; Schneuwly S
    Neuromolecular Med; 2009; 11(4):268-80. PubMed ID: 19855946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease.
    Haywood AF; Staveley BE
    Genome; 2006 May; 49(5):505-10. PubMed ID: 16767175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic models of Parkinson's disease: mechanisms and therapies.
    Whitworth AJ; Pallanck LJ
    SEB Exp Biol Ser; 2008; 60():93-113. PubMed ID: 18309789
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from Drosophila models of DJ-1 deficiency.
    Moore DJ; Dawson VL; Dawson TM
    Sci Aging Knowledge Environ; 2006 Jan; 2006(2):pe2. PubMed ID: 16407572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of α-Synuclein and Disease-Associated Factors in
    Suzuki M; Sango K; Nagai Y
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
    Xun Z; Sowell RA; Kaufman TC; Clemmer DE
    Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.
    Merzetti EM; Dolomount LA; Staveley BE
    Genome; 2017 Jan; 60(1):46-54. PubMed ID: 27936908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
    Goldberg MS; Lansbury PT
    Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coding mutations in
    Guo JF; Zhang L; Li K; Mei JP; Xue J; Chen J; Tang X; Shen L; Jiang H; Chen C; Guo H; Wu XL; Sun SL; Xu Q; Sun QY; Chan P; Shang HF; Wang T; Zhao GH; Liu JY; Xie XF; Jiang YQ; Liu ZH; Zhao YW; Zhu ZB; Li JD; Hu ZM; Yan XX; Fang XD; Wang GH; Zhang FY; Xia K; Liu CY; Zhu XW; Yue ZY; Li SC; Cai HB; Zhang ZH; Duan RH; Tang BS
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11567-11572. PubMed ID: 30348779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flies with Parkinson's disease.
    Vanhauwaert R; Verstreken P
    Exp Neurol; 2015 Dec; 274(Pt A):42-51. PubMed ID: 25708988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.
    Varga SJ; Qi C; Podolsky E; Lee D
    Brain Res; 2014 Oct; 1583():277-86. PubMed ID: 25130663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.